Ecomax, Inc. engages in the search for new business opportunities. The company is headquartered in New York City, New York. The company went IPO on 2001-07-12. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. The company is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción EMAX?
El precio actual de EMAX es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Ecomax Inc?
Ecomax Inc pertenece a la industria N/A y el sector es N/A
¿Cuál es la capitalización bursátil de Ecomax Inc?
La capitalización bursátil actual de Ecomax Inc es $0
